Sign-On Letters
As a part of our advocacy and awareness efforts, HOPA signs on to joint letters to support legislation, voice concerns, and encourage elected officials to continue supporting and funding optimizing cancer care.
This page features the most recent joint letters and statements HOPA has signed, serving as examples of our collaboration with other organizations on topics of common concern.
Statement on CDC Vaccine & Autism Updates from the Society of Infectious Diseases Pharmacists (SIDP)
November 20, 2025 - This sign-on statement from SIDP reacts to the recent changes to the Centers for Disease Control and Prevention's website by reaffirming the science and research-backed conclusions that vaccines do not autism and that they continue to save lives every day.
Statement from Leading Medical, Health, and Patient Advocacy Groups on CDC Autism Website Changes
November 20, 2025 - HOPA signed on to a letter from the American Academy of Pediatrics (AAP) voicing alarm at the Centers for Disease Control and Prevention (CDC) website promoting the outdated, disproven idea that vaccines cause autism.
One Voice Against Cancer (OVAC) Conference Letter Concerning Fiscal Year 2026
November 6, 2025 - This OVAC letter - representing a coalition of more than 50 organizations, including HOPA - urges Congress to enact a final Labor-HHS bill for Fiscal Year 2026 that includes certain funding levels for the NIH, NCI, CDC's cancer prevention and control programs, and the Advanced Research Projects Agency for Health (ARPA-H).
HPNEC Fiscal Year 2026 Conference Year
November 5, 2025 - This Health Professions and Nursing Education Coalition (HPNEC) sign-on letter asks for robust funding for the health workforce in the finalized Fiscal Year 2026 Labor, Health and Human Services, Education, and Related Agencies bill, as well as the highest possible funding for the HRSA Title VII health professions and Title VIII nursing workforce development programs.
ASHP Letter to Centers for Medicare & Medicaid Services on Maximum Fair Price in Inflation Reduction Act
October 30, 2025 - This sign-on letter led by the American Society of Health-System Pharmacists (ASHP) expresses concern with a manufacturer-preferred system concerning maximum fair price (MFP) and asks for the Centers for Medicare & Medicaid Services (CMS) to reject it in favor of requiring manufacturers to apply upfront discounts rather than retrospective rebates.
HPNEC Letter on HRSA Title VII and VIII Program Reauthorization
August 19, 2025 - This sign-on letter, signed by HOPA along with more than 60 other organizations, urges the consideration and advancement of legislation that would reauthorize the Health Resources and Services Administration Title VII health professions and Title VIII nursing workforce development programs.
Coalition for Health Funding (CHF) Letter on Labor, Health and Human Services Fiscal Year 2026 Budget
July 25, 2025 - HOPA, along with more than 500 fellow organizations, signs on to this CHF letter addressing the Departments of Labor, Health and Human Services Fiscal Year 2026 budget and urging for allocations to help reverse past cuts to necessary services and programs.
Joint Pharmacy Letter on Insurance Coverage for Vaccines
July 7, 2025 - This sign-on letter from multiple pharmacy associations and groups urges insurance companies and organizations to maintain their coverage of all currently covered immunizations without new patient cost-sharing or restrictions. This particular letter is addressed to the President and CEO of AHIP, but identical letters were sent to Cigna, Humana, Kaiser, UnitedHealthcare, and Blue Cross Blue Shield.
One Voice Against Cancer (OVAC) Member Sign-On Letter on Fiscal Year 2025 Funds
July 1, 2025 - OVAC addresses a sign-on letter to the Senate Appropriations Subcommittee on Labor, Health and Human Services to fully obligate the remaining Fiscal Year 2025 funds for the NIH and CDC, as well as to reject the cuts to those organizations in the Fiscal Year 2026 budget request.
Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity Act
June 25, 2025 - This press release from the CIACC voices its support for the recent reintroduction of the Cancer Drug Parity Act, which would require group and individual health plans to provide coverage for orally-administered and self-injectable anticancer medications at a cost no less favorable than the cost of IV, port-administered, or injected anticancer medications. The release features a quote from HOPA President Robert Mancini, PharmD, BCOP, FHOPA, joining in support of the Cancer Drug Parity Act.
Comment Letter on Request for Information; Health Technology Ecosystem
June 16, 2025 - This Pharmacy Health Information Technology Collaborative (PHIT) sign-on letter submits comments on the Request for Information; Health Technology Ecosystem.
Infectious Diseases Society of America (IDSA) Letter Supporting the Family Vaccine Protection Act
June 13, 2025 - This sign-on letter from the IDSA offers its strong support for the Family Vaccine Protection Act, which would help protect the full scope of the Advisory Committee on Immunization Practices (ACIP).
Modern Medicaid Alliance (MMA) Letter to Senate Leadership on Medicaid Cuts
June 12, 2025 - The linked sign-on letter from MMA and its supporters expresses concerns and opposition to the harmful Medicaid funding cuts proposed in the House reconciliation package, and urges all Senators to reject the provisions.
Research!America Letter on Proposed NIH Cuts
June 5, 2025 - This sign-on letter respectfully requests that Congress reject the proposed NIH budget cuts - totaling $18 billion - in the President's Fiscal Year 2026 (FY26) budget.
American Association of Colleges of Pharmacy (AACP) Statement on Implications of H.R.1 on Pharmacy Education
May 27, 2025 - This sign-on letter from the AACP expresses concerns about substantial negative consequences of H.R.1, the "One Big Beautiful Bill Act," on the pharmacy workforce pipeline - in particular the proposed elimination of the Grad PLUS loan program, limits on federal student loans, and the proposed institutional risk-sharing measures.
Statement of Cancer Organizations Regarding Importance of Medicaid as a Critical Part of the Nation's Cancer Care System
May 6, 2025 - The linked statement from the Cancer Leadership Council (CLC) details the importance of Medicaid to cancer patients and the potential serious adverse effects of the spending cuts currently under consideration.
One Voice Against Cancer (OVAC) Member Sign-On Letter on Funding Requests for Fiscal Year 2026
April 28, 2025 - This sign-on letter from OVAC members requests funding for cancer research and prevention in the Fiscal Year 2026 Labor, Health and Human Services, and Education Appropriations bill.
Cancer Leadership Council Statement on Elimination of the CDC Division of Cancer Prevention and Control
April 25, 2025 - This letter expresses deep concerns about the recommended elimination of the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention (CDC) in 2025.
Coalition for Health Funding (CHF) Sign-On Letter on Fiscal Year 2026 Budget Cuts
April 25, 2025 - This joint letter expresses concern regarding the Administration’s draft Fiscal Year 2026 budget for the Department of Health and Human Services, proposing to cut approximately one-third of its discretionary spending, critically harming the country's research, scientific, and public health infrastructure.
Comment Letter on the HIPAA Security Rule to Strengthen the Cybersecurity of Electronic Protected Health Information (ePHI)
March 7, 2025 - This sign-on letter led by the Pharmacy Health Information Technology (PHIT) submits comments on the proposed modifications to HIPAA Security Rule to Strength the Cybersecurity of ePHI, supporting the update and modification of HIPAA cybersecurity standards for protected ePHI. However, it does express concerns about a "one-size-fits-all" approach to the additional safeguards.
OVAC Sign-On Statement on Recent Executive Actions That Threaten Progress
February 21, 2025 - HOPA is one of 33 organizations who have signed a letter in support of cancer research funding amid Executive Orders that threaten the stability of research infrastructure.
Letter to Trump Transition Team After 2024 Election
January 17, 2025 - HOPA penned a letter to President-Elect Donald Trump, Vice President-Elect JD Vance, and their transition team after the 2024 presidential election to detail the important role of hematology and oncology pharmacists as well as the key issues HOPA aims to address over the course of their upcoming presidential term.
